News, Policy & Media

27Aug

New Chairman for MHRA

Stephen Lightfoot has been appointed as the Agency’s new Chair from 1st September 2020. He succeeds Prof Sir Michael Rawlins GBE, Kt who has been the Chair of the Agency Board since December 2014.

Stephen has been a Non-Executive Director of the Agency since September 2015 and is also Deputy Chair of Sussex Community NHS Foundation Trust and Non-Executive Chair of Sussex Primary Care Limited.

Before joining the Board, Stephen had a 30-year career in the life sciences industry working on the development and commercialisation of a wide range of medicines and medical devices in UK and global healthcare companies. His most recent executive roles were General Manager of the global pharmaceutical diagnostics business of GE Healthcare, Managing Director of the UK pharmaceutical business of Daiichi Sankyo and Commercial Director of the UK pharmaceutical and medical device business of Schering Healthcare.

BIVDA will be writing to Stephen when he takes up his position to outline the IVD sector's priorities for the MHRA, especially with regard to regulatory regimes post-December 31st when the transition period ends.

Related

Priti Patel has launched the UK's new points-based immigration system which will apply from 1 Ja...

Read More >

NHS England has published its healthcare science strategy for England, outlining how to deliver the ...

Read More >

The Government’s push for community testing uptake from local authorities is showing a high-up...

Read More >

The Government has announced another partnership with four UK universities which will aid in boostin...

Read More >

The global race to find a vaccine for coronavirus is to be bolstered by funding announced as part of...

Read More >

Please find attached a helpful summary of the different customs models used at the various UK ports....

Read More >